- Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms
- Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions
- Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting
Key statistics
On Tuesday, Connect Biopharma Holdings Ltd (CNTB:NMQ) closed at 1.18, 111.74% above the 52 week low of 0.5573 set on May 09, 2022.
52-week range
Open | 1.08 |
---|---|
High | 1.26 |
Low | 1.03 |
Bid | -- |
Offer | -- |
Previous close | 1.18 |
Average volume | 1.60m |
---|---|
Shares outstanding | 55.02m |
Free float | 32.11m |
P/E (TTM) | -- |
Market cap | 64.92m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 21 2023 20:00 BST.
More ▼